Dr. Agarwal's Eye Hospital Limited (DRAGARWQ.BO)
INR 5670.0
(-0.26%)
INR 5670.0
(-0.26%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 904.6 Million | 696.2 Million | 566.8 Million | 338.73 Million | 386.19 Million | 250.69 Million |
| Net Income | 463.6 Million | 369.2 Million | 241 Million | -14.38 Million | 136.83 Million | 119.15 Million |
| Depreciation & Amortization | 266.1 Million | 201.8 Million | 203.9 Million | 190.99 Million | 212.35 Million | 109.12 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 99.8 Million | 49.4 Million | 61.2 Million | 41.72 Million | -27.2 Million | 29.02 Million |
| Other non-cash items | 613.3 Million | 75.8 Million | 60.7 Million | 120.4 Million | 64.2 Million | -6.61 Million |
| Investing Cash Flow | -709.6 Million | -706.1 Million | -462.8 Million | -109.68 Million | -166.71 Million | -248.04 Million |
| Investments in PPE | -713.2 Million | -708.4 Million | -467.3 Million | -111.82 Million | -171.39 Million | -247.97 Million |
| Acquisitions | 10 Million | 700 Thousand | 3.22 Million | 1.64 Million | 4.25 Million | 758 Thousand |
| Investment purchases | -1.4 Million | -400 Thousand | -249 Thousand | -67 Thousand | - | - |
| Sales/Maturities of investments | - | 2.4 Million | 1.82 Million | 635 Thousand | - | - |
| Other Investing Activities | -5 Million | -400 Thousand | -300 Thousand | -67 Thousand | 417 Thousand | -826 Thousand |
| Financing Cash Flow | -140 Million | 2.6 Million | -38.1 Million | -75.99 Million | -199.39 Million | 21.16 Million |
| Debt repayment | -74.7 Million | -90.5 Million | -184.4 Million | -78.62 Million | -65.93 Million | -82.25 Million |
| Dividends payments | -25.8 Million | -14.1 Million | -171 Thousand | -358 Thousand | -8.48 Million | -6.78 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -191.2 Million | 107.2 Million | 146.5 Million | 2.98 Million | -124.96 Million | 110.2 Million |
| Accounts receivables | -37.1 Million | -19.8 Million | -12.17 Million | -39.67 Million | 22.95 Million | -10.85 Million |
| Accounts payables | 68.6 Million | 30.7 Million | 83.42 Million | 57.4 Million | - | - |
| Inventory | -37.5 Million | -2.7 Million | -5.1 Million | 27.62 Million | -14.86 Million | 8.45 Million |
| Other working capital | 105.8 Million | 41.2 Million | -4.94 Million | -3.63 Million | -35.28 Million | 31.42 Million |
| Cash at beginning of period | 274.6 Million | 281.1 Million | 215.2 Million | 62.18 Million | 42.1 Million | 18.28 Million |
| Cash at end of period | 337.4 Million | 273.8 Million | 281.1 Million | 215.24 Million | 62.18 Million | 42.1 Million |
| Capital Expenditure | -713.2 Million | -708.4 Million | -467.3 Million | -111.82 Million | -171.39 Million | -247.97 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 62.8 Million | -7.3 Million | 65.9 Million | 153.05 Million | 20.08 Million | 23.81 Million |
| Free Cash Flow | 191.4 Million | -12.2 Million | 99.5 Million | 226.91 Million | 214.8 Million | 2.72 Million |
| Breakdown | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 463.6 Million | 94.4 Million | 125.9 Million | 115.4 Million | 369.2 Million | 136.8 Million |
| Depreciation & Amortization | 266.1 Million | 68.9 Million | 63.4 Million | 58.5 Million | 201.8 Million | 15.4 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 99.8 Million | - | - | - | 49.4 Million | - |
| Other non-cash items | 613.3 Million | -68.9 Million | -63.4 Million | -58.5 Million | 75.8 Million | -15.4 Million |
| Investing Cash Flow | -709.6 Million | - | - | - | -706.1 Million | - |
| Investments in PPE | -713.2 Million | - | - | - | -708.4 Million | - |
| Acquisitions | 10 Million | - | - | - | 700 Thousand | - |
| Investment purchases | -1.4 Million | - | - | - | -400 Thousand | - |
| Sales/Maturities of investments | - | - | - | - | 2.4 Million | - |
| Other Investing Activities | -5 Million | - | - | - | -400 Thousand | - |
| Financing Cash Flow | -140 Million | - | - | - | 2.6 Million | - |
| Debt repayment | -74.7 Million | - | - | - | -90.5 Million | - |
| Dividends payments | -25.8 Million | - | - | - | -14.1 Million | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | - | - | 107.2 Million | - |
| Accounts receivables | -37.1 Million | - | - | - | -19.8 Million | - |
| Accounts payables | 68.6 Million | - | - | - | 30.7 Million | - |
| Inventory | -37.5 Million | - | - | - | -2.7 Million | - |
| Other working capital | 105.8 Million | - | - | - | 41.2 Million | - |
| Cash at beginning of period | 274.6 Million | 374.5 Million | 248.6 Million | 274.6 Million | 281.1 Million | 137.8 Million |
| Cash at end of period | 337.4 Million | 94.4 Million | 374.5 Million | 115.4 Million | 273.8 Million | 274.6 Million |
| Capital Expenditure | -713.2 Million | - | - | - | -708.4 Million | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 62.8 Million | -280.1 Million | 125.9 Million | -159.2 Million | -7.3 Million | 136.8 Million |
| Free Cash Flow | 191.4 Million | 94.4 Million | 125.9 Million | 115.4 Million | -12.2 Million | 136.8 Million |
7072
0261
RNWF
LDR
100250
ACP